Lifeport LPS7513Recalls & reported problems
Navilyst Medical, Inc. · Lifeport Single Plastic Port System with Attachable 8.4F x 76cm Polyurethane Catheter · Class 2 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H787LPS75130), received between Nov 29, 2017 and Sep 17, 2025 — classified as 2 injuries, 1 malfunction.
The most frequently reported specific device problem is “Fracture” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Fracture3
- Migration2
- Detachment of Device or Device Component1
Patient problems
- Failure of Implant1
- Foreign Body In Patient1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 17, 2025Fracture; Detachment of Device or Device Component; Migration; Fracture; Detachment of Device or Device Component; Migration
ON OR ABOUT ON (B)(6) 2016, PLAINTIFF UNDERWENT LEFT SUBCLAVIAN PLACEMENT OF AN ANGIODYNAMICS LIFEPORT PORT CATHETER PRODUCT, WITH MODEL/REFERENCE NUMBER: LPS7153, AND LOT NUMBER: 4908571. THIS LIFEPORT DEVICE WAS COMPRISED OF A PORT BODY AND A POLYURETHANE CATHETER. THE LIFEPORT DEVICE WAS IMPLANTED BY DR. (B)(6), M.D., AND THE PROCEDURE TOOK PLACE AT (B)(6) HOSPITAL IN (B)(6). THE PURPOSE OF IMPLANTATION OF THE LIFEPORT WAS TO ADMINISTER CHEMOTHERAPY TO TREAT PLAINTIFF'S BREAST CANCER. ON OR ABOUT LATE OCTOBER 2016 TO EARLY NOVEMBER 2016, AFTER COMPLETING ONE COURSE OF CHEMOTHERAPY, PLAINTIFF ENCOUNTERED DIFFICULTY WITH USING THE LIFEPORT AND SUBSEQUENTLY UNDERWENT DIAGNOSTIC IMAGING. ON OR ABOUT ON (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6) HOSPITAL IN (B)(6), TO UNDERGO A VENOGRAM, WHICH REVEALED THE PORT CATHETER DEVICE WAS FRACTURED 5 TO 6 CENTIMETERS INTO THE CATHETER WITH A PORTION LYING FREE IN THE VASCULAR SYSTEM. ON OR ABOUT ON (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6) HOSPITAL IN (B)(6) FOR REMOVAL OF THE CATHETER FRAGMENT THAT HAD BROKEN OFF FROM THE LIFEPORT, AND THE PROCEDURE WAS PERFORMED BY DR. (B)(6), M.D. ON OR ABOUT ON (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6)
Patient problems: Failure of Implant
MAUDE report 23073449 ↗InjuryAug 10, 2021Fracture; Migration; Fracture; Migration
A PATIENT REPORTED VIA THE ANGIODYNAMICS' "CONTACT US" EMAIL REGARDING AN EVENT HE HAD EXPERIENCED WITH A LIFEPORT SL PLA 9 FR W POLY CATH DET. HE REPORTED THE PORT TUBING BROKE AND THE TUBING WAS CLOSE TO WRAPPING AROUND HIS HEART VALVE REQUIRING EMERGENCY SURGERY TO RETRIEVE THE PIECE. HE REPORTED THAT ON (B)(6), HE FELT SICK TO HIS STOMACH. (B)(6) 2021 HE FELT ILL ALL DAY, AND THEN VOMITED SEVERAL TIMES. HE WAS DRIVEN TO THE METHODIST HOSPITAL ER IN HOUSTON, TX WHERE HE NOTIFIED THE ER PHYSICIAN HE HAD STAGE 4 NSCLC. A CT SCAN WAS IMMEDIATELY PERFORMED WHERE THE ER PHYSICIAN DISCOVERED THE PIECE. HE WAS THEN TRANSFERRED TO HOUSTON METHODIST HOSPITAL. ON (B)(6), THE PATIENT HAD SURGERY TO RETRIEVE THE PIECE AND REMOVE THE PORT. (B)(6), THE PATIENT WAS RELEASED FROM THE HOSPITAL AFTER THREE DAYS. THE PATIENT REPORTED THAT ON (B)(6), HE HAS A FOLLOW UP APPOINTMENT WITH THE TREATING SURGEON. THE PORT WAS NOT REPLACED AND HE IS TAKING CURRENTLY ALENSA FOR TREATMENT. THE REPORTED DEVICE IS NOT AVAILABLE TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION.
Patient problems: Foreign Body In Patient
MAUDE report 12299944 ↗InjuryNov 29, 2017Fracture; Fracture
AS REPORTED, THE CATHETER PORTION OF AN INDWELLING VORTEX PORT FRACTURED APPROXIMATELY 2" FROM THE PORT SITE. IT WAS REMOVED FROM THE PATIENT ON (B)(6) 2017. THE PORT HAD BEEN INDWELLING FOR 16 YEARS (ORIGINALLY PLACED ON (B)(6) 2001). NO PATIENT INJURY OR COMPLICATIONS WERE REPORTED. THE USED DEVICE WAS RETURNED TO ANGIODYNAMICS FOR EVALUATION.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7067928 ↗
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page